The trial which is said to be in phase 2B will conduct trials on about 2 600 healthy people, specifically, adults and will evaluate the safety, efficiency and immunity of 249 medically stable HIV positive adults as well.
Since South Africa was in its winter season and experiencing a winter surge of infections, Novavax research chief Gregory Glen said that the trial has the potential to provide an early indication of efficacy.
Currently, South Africa is the fifth-worst affected country with 583,000 coronavirus cases and 18 000 fatalities. The president took the country to level 2 in a brief speech last night. This has a risk of surging cases again but the good thing is that many more industries, businesses and jobs will reopen and the country will be taking a step further into recovery.
Content created and supplied by: Traysee (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More